首页> 外文期刊>Blood: The Journal of the American Society of Hematology >HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo.
【24h】

HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo.

机译:HIV-1诱导的CD4 + T细胞活化为离体人类淋巴组织的HIV-1感染创造了新的靶标。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We demonstrate mechanisms by which HIV-1 appears to facilitate its own infection in ex vivo-infected human lymphoid tissue. In this system, HIV-1 readily infects various CD4+ T cells, but productive viral infection was supported predominantly by activated T cells expressing either CD25 or HLA-DR or both (CD25/HLA-DR) but not other activation markers: There was a strong positive correlation (r=0.64, P=.001) between virus production and the number of CD25+/HLA-DR+ T cells. HIV-1 infection of lymphoid tissue was associated with activation of both HIV-1-infected and uninfected (bystanders) T cells. In these tissues, apoptosis was selectively increased in T cells expressing CD25/HLA-DR and p24gag but not in cells expressing either of these markers alone. In the course of HIV-1 infection, there was a significant increase in the number of activated (CD25+/HLA-DR+) T cells both infected and uninfected (bystander). By inducing T cells to express particular markers of activation that create new targets for infection, HIV-1 generates in ex vivo lymphoid tissues a vicious destructive circle of activation and infection. In vivo, such self-perpetuating cycle could contribute to HIV-1 disease.
机译:我们展示了HIV-1似乎促进离体感染人类淋巴组织自身感染的机制。在该系统中,HIV-1容易感染各种CD4 + T细胞,但生产性病毒感染主要由表达CD25或HLA-DR或两者(CD25 / HLA-DR)但不包含其他激活标志物的活化T细胞支持。病毒产量与CD25 + / HLA-DR + T细胞数量之间存在强正相关(r = 0.64,P = .001)。淋巴组织的HIV-1感染与HIV-1感染和未感染(旁观者)T细胞的激活有关。在这些组织中,在表达CD25 / HLA-DR和p24gag的T细胞中选择性地增加了细胞凋亡,但在仅表达这些标记之一的细胞中却没有选择性地增加细胞凋亡。在HIV-1感染的过程中,被感染和未被感染(旁观者)的活化(CD25 + / HLA-DR +)T细胞数量显着增加。通过诱导T细胞表达特定的激活标记,从而创建新的感染靶标,HIV-1在离体淋巴组织中形成了一个激活和感染的恶性破坏圈。在体内,这种自我延续的循环可能导致HIV-1疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号